APA-referens

Miyauchi, S., Sanders, P. D., Guram, K., Kim, S. S., Paolini, F., Venuti, A., . . . Sharabi, A. B. (2019). HPV16 E5 Mediates Resistance to PD-L1 Blockade and can be targeted with Rimantadine in Head and Neck Cancer. Cancer Res.

Chicago-stil citat

Miyauchi, Sayuri, et al. "HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted With Rimantadine in Head and Neck Cancer." Cancer Res 2019.

MLA-referens

Miyauchi, Sayuri, et al. "HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted With Rimantadine in Head and Neck Cancer." Cancer Res 2019.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.